<i>KALRN</i> mutations promote antitumor immunity and immunotherapy response in cancer

Mengyuan Li(Second Affiliated Hospital of Zhejiang University), Xiaosheng Wang(China Pharmaceutical University)
Journal for ImmunoTherapy of Cancer
October 1, 2020
Cited by 23


Related Papers